What Now? US Cosmetic Review Has Evaluated Up To 91% Of Ingredients Used Nationwide
Executive Summary
CIR’s work is far from done, says executive director Bart Heldreth, citing the cosmetics industry's vibrant innovation tradition and ingredient re-review needs that should keep the program sufficiently busy.
You may also be interested in...
CIR Expert Panel Wraps Five Ingredient Safety Assessments, Finalizes 2022 Priorities
Meeting virtually on 13-14 September, Cosmetic Ingredient Review's independent expert panel issued final safety assessments for red algae, tea tree and three other ingredients/groups, as well as eight tentative reports and five insufficient data announcements. The group also finalized its review priorities for 2022.
US Cosmetics Modernization Bill Relaunched, Now With Fragrance Allergen Labeling, PFAS Ban
The Personal Care Products Safety Act was reintroduced in the US Senate on 17 June with industry support including leading brands at big-name multinationals. The latest “Feinstein bill” for modernizing US cosmetics regulations purports to strengthen counterfeit product protections while floating additional requirements for fragrance allergen labeling and banning intentionally added PFAS.
Cosmetic Ingredient Innovation In An Increasingly Cruelty-Free World; Is It Possible?
Visibility is low into the availability of new cosmetic ingredients since 2013, but there does appear to be a viable pathway for innovations to reach the EU market, despite the animal testing ban, as well as California, where similar prohibitions will go into effect in 2020. Still, industry’s best bet is to continue investing in alternative methods development and promoting their acceptance with regulators.